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Human embryonic stem cells (hESCs) share an
identical genome with lineage-committed cells, yet
possess the remarkable properties of self-renewal
and pluripotency. The diverse cellular properties in
different cells have been attributed to their distinct
epigenomes, but how much epigenomes differ
remains unclear. Here, we report that epigenomic
landscapes in hESCs and lineage-committed cells
are drastically different. By comparing the chro-
matin-modification profiles and DNA methylomes in
hESCs and primary fibroblasts, we find that nearly
one-third of the genome differs in chromatin struc-
ture. Most changes arise from dramatic redistribu-
tions of repressive H3K9me3 and H3K27me3 marks,
which form blocks that significantly expand in
fibroblasts. A large number of potential regulatory
sequences also exhibit a high degree of dynamics
in chromatin modifications and DNA methylation.
Additionally, we observe novel, context-dependent
relationships between DNA methylation and chro-
matinmodifications. Our results provide new insights
into epigenetic mechanisms underlying properties of
pluripotency and cell fate commitment.
INTRODUCTION
Pluripotent embryonic stem cells (ESCs) possess the ability to
differentiate into multiple cell lineages in the body (Thomson
et al., 1998). The underlying molecular mechanisms of pluripo-
tency and cell fate commitment have not been completely under-
stood. At least two models account for differences between
pluripotent stem cells and lineage-committed cells. In the first,‘‘master switches’’ activate distinct networks of transcription
factors that govern the transcriptional program of each cell type
and dictate cellular properties (Marson et al., 2008). For example,
the OCT4/SOX2/NANOG network enables self-renewal proper-
ties of ESCs, and ectopic expression of these factors together
with additional transcription factors reprogram somatic cells
into pluripotent cells (iPSCs) (Takahashi et al., 2007; Takahashi
and Yamanaka, 2006; Yu et al., 2007). But the efficiency of
reprogramming is low, suggesting the involvement of additional
factors or mechanisms. Additionally, lineage-committed cells
are stable over many cell divisions, after the initial master switch
transcription factors are no longer expressed. Such a phenom-
enon, referred to as ‘‘cellular memory,’’ has been difficult to
explain by the transcription factor network model (Ringrose
and Paro, 2004).
Another model for cellular memory involves the cell’s epige-
nomic landscape consisting of covalent modifications to DNA
or histones (Ringrose and Paro, 2004), which either enable or
prevent parts of the genome to be active in different cell types.
In stem cells, the epigenome is highly malleable and responsive
(Meshorer and Misteli, 2006), unlike that of somatic cells.
Multiple lines of evidence support this model. First, ESCs have
a higher number of ‘‘bivalent’’ or ‘‘poised’’ promoters marking
important developmental regulators compared to differentiated
cells, as indicated by the repressive mark histone H3 lysine 27
trimethylation (H3K27me3) and the active chromatin modifica-
tion H3K4me3 (Azuara et al., 2006; Bernstein et al., 2006;
Pan et al., 2007). Second, immunofluorescent imaging showed
that after differentiation, mouse ESCs display increased hetero-
chomatin in the nucleus (Meshorer and Misteli, 2006). Addition-
ally, depletion of the Jmjd1a and Jmjd2c demethylases for the
heterochromatin modification H3K9me3 results in stem cell
differentiation (Loh et al., 2007). Third, DNA methylation is
found at the promoters of critical pluripotency genes such as
Oct4 during differentiation and is responsible to keep such
genes silent in differentiated cells (Ben-Shushan et al., 1993;
Deb-Rinker et al., 2005).Cell Stem Cell 6, 479–491, May 7, 2010 ª2010 Elsevier Inc. 479
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Distinct Epigenomic Landscapes in Human CellsRecent large-scale analyses of DNA methylation and histone
modifications revealed dynamic chromatin states and DNA
methylation status at promoters and most CpG islands (Brunner
et al., 2009; Meissner et al., 2008), showing that the methylation
state of H3K4 is a good indicator of promoter DNA methylation
levels in mammalian cells. This is consistent with prior studies
indicating that H3K4 methylation disrupts DNA methylation by
inhibiting contact of DNMTs with histones, whereas promoters
marked only with H3K27me3 in mouse ESCs are more likely to
exhibit de novo DNA methylation after differentiation (Meissner
et al., 2008; Mohn et al., 2008). Although these insights suggest
potential mechanisms of epigenetic regulation at promoters, the
epigenetic regulatory mechanisms outside of promoters remains
largely unclear.
Toobtainabetterunderstandingof theepigenomic landscapes
in the pluripotent and differentiated cell states and explore the
links between histone modifications and DNA methylation
throughout thegenome,weconductedacomprehensiveanalysis
of 11 histone modifications and a recently acquired genome-
wide nucleotide resolution map of DNAmethylation in H1 human
embryonic stem cells (hESCs) and fetal lung fibroblasts (IMR90)
(Lister et al., 2009). We show a large-scale expansion of
H3K9me3 and H3K27me3 domains in differentiated cells relative
to hESCs,which selectively affects genes related to pluripotency,
development, and lineage-specific functions. We also find multi-
ple epigeneticmechanismsbywhichkeypluripotent transcription
factors are silenced in somatic cells. Finally, our analysis of both
cell types reveals context-dependent, complex relationships
between chromatin modifications and DNA methylation.
RESULTS AND DISCUSSION
Chromatin Modification Landscapes
We performed ChIP-Seq (Johnson et al., 2007) experiments to
identify global histone modification patterns for H2BK5ac,
H3K4me1, H3K4me2, H3K4me3, H3K9ac, H3K9me3, H3K18ac,
H3K27ac, H3K27me3, H3K36me3, and H4K5ac. Antibodies
were validated for specificity with peptide dot blot assays and
western blotting (Figure S1 available online). ChIP-Seq experi-
ments produced 5 to 40 million monoclonal, uniquely mapped
tags per chromatin modification and input DNA for well-corre-
lated biological replicates in H1 hESCs and IMR90 fibroblasts
(Figure 1; TableS1).Wechoseacetylationmarks,whichare indic-
ative of open chromatin, as well as H3K4 methylation marks
featured at active enhancers and promoters (Heintzman et al.,
2007, 2009). We contrasted this architecture with the repressive
structures ofH3K27me3andH3K9me3and thegenic localization
of H3K36me3, a transcription elongation-coupled chromatin
mark (Krogan et al., 2003; Li et al., 2002).
Visualization of these maps indicates that histone modifica-
tions show twodistinct types of spatial distributions: small, punc-
tuated peaks and large, spreading domains (Figure 1). Modifica-
tions such as H3K4 methylation and acetylation are typically
found in peak-like structures (Figures 1A and 1B), whereas
H3K36me3, H3K27me3, and H3K9me3 are usually seen in broad
domains of varying widths (Figures 1A, 1C, and 1D). It is possible
that these two types of chromatin-modification patterns corre-
spond to distinct physical structures of chromatin fibers in vivo
(Figure 1E).480 Cell Stem Cell 6, 479–491, May 7, 2010 ª2010 Elsevier Inc.Most peak-finding programs rely on the assumption of
stranded distributions of tags at peaks, and as such cannot
detect the broad domains typical of histone modifications
(Kharchenko et al., 2008; Zhang et al., 2008). To systematically
enumerate genomic regions enriched for chromatin modifica-
tions, we devised a computational method called Chroma-
Blocks, which is tailored to identify both peak-like structures
and large chromatin domains from ChIP-Seq data (see Experi-
mental Procedures). This analysis yielded between 9,414 and
43,536 blocks for each chromatin modification in hESC or
IMR90, occupying between 68 million and 510 million base pairs
(Table S2). Analysis with permuted data indicates that this
method is highly specific (median FDR = 0.97%, Table S2) and
approaches saturation around 10 million unique monoclonal
reads (Figures S2D–S2G). With this tool in place, we are able
to assess varying chromatin structures and compare how the
chromatin landscape of hESCs differs from that of differentiated
cells.
Redistribution of Large Domains of Chromatin
Modifications
Comparing the domains in hESC and IMR90, we find that the
chromatin architecture at a surprisingly large fraction of the
genome is different (Figures 2A and 2B). Many of the H3K9me3
domains in hESCs appear small and interspersed (median
length = 6.9 kb) but are expanded significantly in IMR90 cells
(median length = 11.4 kb, p < 1E-15) (Figures 2A, 2C, and 2D;
Tables S3 and S4). Correspondingly, the number of base
pairs spanned by H3K9me3 in IMR90 (510 Mb) is 3.4 times
larger than in hESCs (148 Mb) (Figure 2C). Similarly, the number
of base pairs spanned by H3K27me3 domains in IMR90 (394
Mb) is 3.3 times more than in hESCs (119 Mb) (Tables S5
and S6). The median size of an H3K27me3 domain in IMR90
(16,400 bp) expands to almost twice that of hESCs (8600 bp,
p < 1E-308, Wilcoxon rank sum test; Figure 2C), whereas cover-
age of H3K36me3 domains remains consistent (hESC median =
15,700 bp; IMR90 median size = 16,900 bp, p = 4.6E-7) (Fig-
ures 1A, 2C, and 2D). In total, 50% of the IMR90 genome is
spanned by chromatin domains from the 11 marks profiled,
whereas only 32% of the hESC genome is in chromatin domains
(Figure 2E). The difference is largely accounted for by H3K27me3
and H3K9me3 dispersal (Figures 2D, 2F, and 2G). Each of these
marks covers 4% of the hESC genome, but expands to 12%
(H3K27me3) and 16% (H3K9me3) in IMR90 cells (Figures 2F
and 2G).
To confirm whether expansion of repressive domains is a key
characteristic of differentiated cell fate, we tested whether
expanded domains exist in other cells. We analyzed genome-
wide profiles of H3K27me3 in CD4+ T cells (Barski et al., 2007;
Cuddapah et al., 2009). Indeed, much of the CD4+ T cell genome
(324 Mb) is spanned by H3K27me3 domains, nearly three times
as large as in hESCs. Because of insufficient read depth for
H3K9me3 in this cell type, we did not include H3K9me3
blocks in this analysis. The expansion of H3K27me3 holds
true in various differentiated cell types. ChromaBlocks analysis
of H3K27me3 shows expansion in nontransformed HUVEC
(347 Mb) and NHEK (312 Mb) cells, as well as transformed
GM12878 lymphoblasts (286 Mb) and K562 leukemia cells
(353 Mb) (Figure S3A; data produced and released from the
Figure 1. Histone Modifications Form Block Structures
(A–D) AnnoJ Browser snapshots of representative examples of the relationship between histone modifications and DNA methylation. Strand-specific mapped
tags are displayed above (green) and below (red) the line. Strand-specific DNAmethylation (mC): mCG (yellow-green bars), mCHG (blue bars), mCHH (pink bars).
(A) The p300 (EP300) locus illustrating depleted mCG in the promoter containing H3K4me3, and H3K36me3 in the gene body of both cell types.
(B) H3K4me1 and H3K27ac occur at both the promoter of LRP5 and distal sites that show differences in mCG.
(C) H3K27me3 is present at the mCG-depleted promoter of the developmental transcription factor HAND1. Spreading of H3K27me3 in IMR90 cells accounts for
correlated differences with mCG.
(D) The NLRP gene cluster is encompassed by H3K9me3 in both cells types, a reduction in mCG is evident in IMR90 cells.
(E) A schematic of the ChromaBlocks strategy for identifying chromatin domains from input-normalized ChIP-Seq data.
See also Figure S1, Table S1.
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types examined, normal and cancer cell types, have a clear
increase in repressive chromatin structure compared to hESCs.
In contrast, modifications associated with gene activity including
H3K4me1, H3K4me2, H3K4me3, H3K27ac, and H3K36me3 are
not expanded in these differentiated cell lines compared to
hESCs (data not shown).
Expansion of H3K27me3 and H3K9me3 Selectively
Affects Developmental Genes
We investigated the extent to which genes are silenced in
fibroblasts compared to hESCs by broad domains. Despite
expansion of H3K27me3 domains, we observed similar numbers
of promoters covered by H3K27me3 in hESCs (4736) and
IMR90 cells (4279) (Figures S3B and S3C). However, 83% of
H3K27me3-marked promoters are H3K4me3/H3K27me3 biva-lent promoters in hESCs, compared to 50% in IMR90 cells
(Figure 3A). Of the 2485 promoters commonly marked by
H3K27me3 in hESCs and IMR90 cells, 1512 show greater than
50% expansion in IMR90 cells. The median H3K27me3 domain
spanning a promoter in hESCs is 10 kb, compared to 28 kb in
IMR90 and 22 kb in CD4+ T cells, suggesting that expansion of
H3K27me3 domains is a common feature of differentiated cells
(Figure S3).
Gene ontology (GO) analysis via DAVID (Dennis et al., 2003)
of genes marked by H3K27me3 expansion in IMR90 cells
reveals significant enrichment in developmental processes
(Figure S3D), including genes from the BMP, FGF, FOX, SOX,
and GATA families (Table S7). Additionally, GO analysis on the
314 promoters marked by H3K27me3 expansion in hESCs
compared to IMR90 cells revealed significant enrichment of
a small class of developmental proteins including brain-specificCell Stem Cell 6, 479–491, May 7, 2010 ª2010 Elsevier Inc. 481
Figure 2. Features of Chromatin Domains
(A and B) Examples of (A) H3K9me3 and (B)
H3K27me3 domains expanded in IMR90 cells
relative to hESCs.
(C and D) The total number of base pairs spanned
by domains (C) and the distribution of domain
sizes for all mapped chromatin modifications (D).
IMR90, white; hESC, gray.
(E) The fraction of the human genome spanned by
the 11 chromatin modifications profiled in both cell
types.
(F and G) The fraction of the (F) hESC and (G)
IMR90 genomes spanned by H3K9me3 and
H3K27me3 domains.
See also Figures S2 and S3, Tables S2–S6.
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Distinct Epigenomic Landscapes in Human Cellsgenes suchasEMX2andBAI1, aswell as severalHOXgenes. The
bivalent ESC-chromatin state often transitions toH3K27me3 and
expands to cover the entire gene locus and frequently neigh-
boring gene loci. An additional 1742 promoters are marked by
H3K27me3 only in IMR90 cells but not in hESCs and are enriched
for nondevelopmentally related biological processes including
immune and defense response (Figure S3D). Interestingly,
distinct genes are marked by expanded H3K27me3 domains in
IMR90 and CD4+ T cells. There are 2138 promoters marked by
H3K27me3 in hESCs that expand in IMR90 or CD4+ cells. Of482 Cell Stem Cell 6, 479–491, May 7, 2010 ª2010 Elsevier Inc./
lthese, 929 (44%) are IMR90 specific
and 626 (29%) exhibit CD4+-specific
expansion, whereas 583 (27%) expand
in both cells. IMR90-specific expanded
domains are enriched for T cell, B cell,
and lymphocyte-related genes, whereas
CD4+-specific expanded domains are
enriched for extracellular matrix proteins,
such as collagens. These results suggest
thatcell fatecommitment isalsoaprocess
of epigenetic gene repression that is
unique to different lineages.
Similar to H3K27me3, there are 45%
more H3K9me3-only marked domains in
IMR90 cells (659) than in hESCs (456).
However, a smaller fraction of gene
promoters are spanned by H3K9me3
domains in hESCs (932, 5%) and IMR90
cells (1448, 8%) (overlap 456 promoters)
(Figures 2C, 2F, 2G and 3A). In several
instances, gene family clusters are
marked by H3K9me3 domains, including
olfactory receptors (OR) and the NLRP
(Figure 1D), KRTAP, LCE, and zinc
finger (ZNF) families. Notably, H3K9me3
spreading covers the gene encoding the
early developmental factor DPPA3 in
IMR90 cells, and this spreading ends
immediately before NANOG. Interest-
ingly, we observe five times as many
promoters simultaneously marked by
H3K9me3 and H3K27me3 in IMR90
cells (359) as in hESCs (71) (Figure 3A).For example, the Simpson-Golabi-Behmel overgrowth syn-
drome gene, GPC3 (Pilia et al., 1996), is bivalent (H3K4me3
H3K27me3) and expressed in hESCs, yet is repressed by
H3K9me3 and H3K27me3 in IMR90 cells (Figure 3B). Addition-
ally, we observe key developmental transcription factors associ-
ated with both H3K9me3 and H3K27me3 in IMR90 cells. As
examples, POU3F4 and PAX3 are marked by H3K27me3 in
hESCs and gain H3K9me3 in IMR90 cells to become dually
marked for repression (Figures 3C and 3D). POU class transcrip-
tion factors establish cell type-specific gene expression and cel
Figure 3. Expansion of Distinct Chromatin
Blocks Marks Developmental Genes
(A) The number of promoters marked by vari-
ous combinations of chromatin modifications in
hESCs (black) and IMR90 cells (white). Exact
combinations, including H3K4me3, can be found
for RefSeq genes in Table S7. Abbreviations: K4,
H3K4me3; K9, H3K9me3; K27, H3K27me3;
none, lacking K4/K9/K27.
(B–D) Snapshots of domains and chromatin struc-
ture around promoters that gain H3K9me3 and
H3K27me3 in IMR90 cells, for (B) GPC3, (C)
POU3F4, and (D) PAX3.
(E and F) Gene ontology - biological processes
enriched in promoters that are marked by both
H3K9me3 andH3K27me3 in IMR90 cells (E), along
with (F) examples of developmentally relevant
genes having this chromatin structure.
See also Figure S3, Table S7.
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critical for cell fate, organogenesis, and proliferation, leading
to an important role in cancer (Loh et al., 2006). In light of this,
we asked whether H3K9me3/H3K27me3-marked promoters
in IMR90 cells share similar functions. GO analysis revealed
significant enrichment for developmental processes, including
multicellular organismal development, system development,
and anatomical structure development (Figure 3E), noting that
manydual-markedpromoters include keydevelopmental regula-
tors (Figure 3F), such as HOX genes. The colocalization of
H3K27me3 and H3K9me3 at genes was recently noted by others
(Bilodeau et al., 2009). Not all H3K27me3-marked sites are asso-
ciatedwith H3K9me3. This dual repression at specialized regula-
tors may point to the importance of maintaining their silencing in
differentiated cells. These genes serve as likely candidates for
cell fate decisions.
With distinct spatial modes of H3K9me3- and H3K27me3-
marking genes, we asked how these modes affect gene repres-
sion. We considered four cases: (1) promoters not marked in
hESCsbutmarked in IMR90cells (appear), (2) promoters covered
by blocks in hESCs but expanded by at least 50% in IMR90 cells
(expand), (3) promoters unmarked in both cells (unmarked), andCell Stem Cell 6, 479(4) promoters marked by similarly sized
blocks in both cells (marked). Table S7
shows the H3K4-, K9-, and K27-me3
states for all genes and expression
changes. The acquisition of H3K9me3
at promoters showed the most significant
decrease in gene expression (p = 0.011)
compared to the other H3K9me3 sce-
narios (Figures 4A, 4C, and 4D). In con-
trast, the greatest repression for
H3K27me3 cases occurred upon do-
main expansion (Figures 4B, 4E, and 4F).
This may imply that the presence of
H3K9me3 alone is enough to suppress
gene expression and expansion of
domains has a smaller effect on gene
repression. By contrast, the presence ofnarrowly marked H3K27me3 promoters is frequently insufficient
to silence a gene (Figure 4F), as they are often in a bivalent state,
but the expansion seems to maintain stable silencing of gene
expression in the differentiated cells (p = 1.3E-19).
Global Analysis of Associations between Chromatin
Modifications and DNA Methylation
DNA methylation is a critical component of the epigenome that
represses gene expression through promoter CG methylation,
in addition to being localized at heterochromatin and repetitive
elements in the genome. This mark is thought to maintain
long-term repression and to be less dynamic than histone modi-
fications. There is also evidence that some crosstalk between
these epigenetic mechanisms exists, suggesting a direct link
between H3K9 methyltransferases (HKMT) and DNA methyl-
transferases (DNMTs) (Fuks et al., 2003; Jackson et al., 2002;
Lehnertz et al., 2003; Li et al., 2006; Tamaru and Selker, 2001).
However, mutations in the SET domain of HKMT G9a do not
alleviate DNA methylation (Dong et al., 2008; Tachibana et al.,
2008). To date, it remains to be determined whether other chro-
matin structures or regulatory elements have an association with
DNA methylation.–491, May 7, 2010 ª2010 Elsevier Inc. 483
Figure 4. Expression of Genes in Different Types of Chromatin Domains
(A) Change in gene expression for promoters where H3K9me3 appears, expands, remains unmarked, or remains similarly marked in IMR90 cells compared
to hESCs.
(B) As in (A), but for H3K27me3.
(C–F) Snapshots of genes exhibiting (C) H3K9me3 appearance, (D) H3K9me3 expansion, (E) H3K27me3 appearance, and (F) H3K27me3 expansion, as observed
in IMR90 cells relative to hESCs.
See also Table S7.
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methylation (mC) generated in H1 hESCs and IMR90 cells (Lister
et al., 2009), we systematically investigated the relationships
between the 11 chromatin modifications described above and
DNA methylation. By using a sliding window approach, we
plotted the presence of ChIP-Seq tags for each histone modifi-
cation normalized to input, against the average percentage of
CG methylation (mCG) in the same window, to determine the
association of the two epigenetic components in hESCs and
IMR90 (Figures 5A–5D; Figure S4). Consistent with previous find-
ings, we observe that H3K4me3 is inversely correlatedwithmCG484 Cell Stem Cell 6, 479–491, May 7, 2010 ª2010 Elsevier Inc.(Figures 1A and 5A). Similarly, H3K27me3 is associated with
hypomethylation of DNA at promoters, consistent with previous
observations that bivalent promoters are typically hypomethy-
lated (Brunner et al., 2009; Meissner et al., 2008). Outside of
promoters, H3K27me3 is also positively associated with DNA
methylation across a broad range of mCG. Interestingly, the
degree of association between H3K9me3 and DNA methylation
is less prevalent than that between mCG and H3K36me3, which
is always associated with fully methylated DNA in both hESCs
and IMR90 cells (Figures 1A, 5B, and 5D). These results suggest
cell type-specific relationships between DNA methylation and
Figure 5. Genome-wide Correlation Anal-
ysis between Histone Modifications and
Methylated CG
(A–D) Change in RPKM for several histone modifi-
cations relative to input control were calculated
within 2.5 kb window for (A) H3K4me3 and
5 kb for (B) H3K9me3, (C) H3K27me3, and (D)
H3K36me3, and plotted against %mCG in the
same window throughout the genome. Density of
spots in the plot is displayed by the heatmap
(right).
(E) For H3K9me3 (left), H3K27me3 (middle), and
H3K36me3 (right), spreading chromatin domains
were identified as IMR90 domains having at
most 20% overlap with hESC domains. Shown is
the IMR90 to hESC ratio of %mCG for each of
these domains, as a function of domain size.
(F–H) Representative punctuated chromatin sig-
natures. ChromaSig was used to simultaneously
cluster and align all 11 chromatin modifications
mapped from both cell types at (F) promoters,
(G) predicted enhancers, and (H) regions of
ChIP-Seq enriched sequences. On the left are
the chromatin signatures recovered for each
cluster, and on the right are %mCG tracks
appended after clustering. Enrichment of histone
modifications and %mCG are indicated by the
heatmap (bottom). The number of genomic loci
in each cluster is indicated on the far right.
Average profiles for each modification are plotted
beneath the representative clustergrams. Profiles
are color-coordinated with the cluster ID, e.g., P1
(red), P3 (green), P5 (blue), P14 (black).
See also Figures S4–S7, Tables S8–S12.
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Figure S4).
H3K36me3 and DNA methylation have been described in
exons of transcribed gene bodies (Ball et al., 2009; Hellman
and Chess, 2007; Kolasinska-Zwierz et al., 2009). Examining
the enrichment of H3K36me3 and mCG across 231,984
human exons, we observe that there is concordance between
H3K36me3 and mCG (Figures S5A and S5B). However,
H3K36me3 is more positively correlated with gene expression
(Figures S5C and S5D), as indicated by the fact that most exons
are marked with DNA methylation (Figures S5A and S5B).
A possible mechanism may involve H3K36me3 in the recruit-
ment of DNA methyltransferases to maintain DNA methylation
at transcribed gene bodies. This would fit the ‘‘methylation
paradox,’’ noting that although promoter CpG islands remain
unmethylated, transcribed CpG islands show an increase inCell Stem Cell 6, 479DNA methylation (Jones, 1999). How-
ever, DNA methylation is also found
outside transcribed regions. Therefore,
whereas H3K36me3 predicts DNA meth-
ylation, the converse is not true.
To assess how changes in chromatin
blocks correlate with changes in DNA
methylation, we analyzed the genomic
regions that were differentially marked in
IMR90. Regions of the genome uniquelymarked by H3K9me3 in IMR90 cells contain roughly half as
much mCG as in hESCs (Figure 5E; Figures S5E–S5G). This
depletion is most evident for larger domains, whereas small
domains have a wide variance of mCG. Similarly, H3K27me3
domains unique to IMR90 cells are also depleted of mCG
relative to hESCs, though at levels intermediate to H3K9me3
and H3K36me3 blocks, which exhibit equivalent levels of
DNA methylation in each cell type (Figures 5E and 5F; Figures
S5E–S5G). This intermediate level of methylation is not due to
the contribution of promoters (Figure S5H). These relationships
hold when comparing domains marked in both hESCs and
IMR90 cells. Together, these results suggest that, on a global
scale, gain of the repressive modifications H3K27me3 or
H3K9me3 is associated with a corresponding decrease in DNA
methylation level in the differentiated IMR90 cells. This observa-
tion suggests a much more complex relationship between–491, May 7, 2010 ª2010 Elsevier Inc. 485
Figure 6. Distinct Modes of Epigenetic
Repression at Developmental Genes
(A) Snapshots of chromatin modifications and
DNA methylation around OCT4, SOX2, and
NANOG in hESCs and IMR90 cells, illustrating
distinct transitions to repressive epigenetic states.
Abbreviations: K4, H3K4me3; K9, H3K9me3; K27,
H3K27me3; mC, DNA methylation.
(B) Unsupervised clustering of H3K4me3,
H3K9me3, H3K27me3, and mCG at promoters of
genes downregulated by 2-fold in IMR90 cells
relative hESCs. Relevant genes are indicated
to the left. Distinct clusters are noted on the
right. The enrichment scale is shown below the
heatmap.
(C) GO analysis of genes whose promoters remain
bivalent (H3K4/K27me3),acquireH3K9me3 (H3K4/
K27me3 to H3K9/K27me3), or lose H3K4me3
(H3K4/K27me3 to H3K4me3) in IMR90 cells.
See also Table S7.
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proposed (Cedar and Bergman, 2009; Suzuki and Bird, 2008).
DNA Methylation at Potential Regulatory Sequences
A complex relationship also exists betweenmCG and H3K4me1,
H3K4me2, and histone acetylation, which mark active regulatory
sequences such as promoters and enhancers (Figures 5A–5D;
Figure S7). To relate complex patterns of histone modifications
with mCG at functional elements, we utilized an unbiased clus-
tering algorithm, ChromaSig (Hon et al., 2008). By focusing on
modifications with a punctuated footprint (Figures 5F–5H;
Figure S6, all clusters), our analysis revealed 42 frequently occur-
ring patterns, grouped into three categories corresponding to
known promoters (Figure 5F; Figure S6A, Table S8), H3K4me1-
predicted enhancers (Figure 5G; Figure S6B, Table S9), and
other regions with enriched chromatin modification signals,
ChIP-rich regions (Figure 5H; Figure S6C, Table S10).486 Cell Stem Cell 6, 479–491, May 7, 2010 ª2010 Elsevier Inc.r
,
rAlthoughmost promoters have a strong
inverse correlation between H3K4me3
and mCG, a subset of gene promoters
lacking chromatin modifications are
hypermethylated and typically silenced
(Figure 5F; Figures S6A, S7A, and S7D).
At enhancers (Tables S11 and S12), cell-
specific relationships exist. Acetylated,
IMR90-specific enhancers (Figure 5G,
clusters E1-E3, E10-E11) show depletion
of mCG in IMR90 cells, but not in hESCs
(cluster E2). Nonacetylated IMR90-spe-
cific enhancers have minimal mCG
depletion (cluster E9). At shared en-
hancers (E5, E7, E8), both cell types
have mCG depletion (Figure 5G, E7)
whereas hESC-specific enhancers (E4,
E6, E12) show no obvious depletion of
mCG (E4 in Figure 5G; Figures S6B,
S7B, and S7E). Instead, hESC enhancers
and transcription factor binding sites foOCT4, SOX2, NANOG, and others are depleted of non-CGmeth-
ylation (Lister et al., 2009). Therefore, the chromatin modifica-
tions at these elements are largely cell specific and are inversely
related to DNA methylation in a cell-specific manner. However
the mechanism for the role of CG versus nonCG methylation is
unclear.
ChromaSig analysis of ChIP-rich regions outside of known
promoters and predicted enhancers confirmed our block
analysis, illustrating H3K36me3 regions enriched for mCG
(Figure 5H, cluster C2; Figure S6C, cluster C1–C3) and the pres-
ence of peak-like H3K9me3 sites in hESCs (Figure 5H, cluste
C5). ChromaSig also detects patterns missed by peak-finding
or prediction algorithms. Cluster C12 illustrates likely IMR90
cell-specific enhancers previously missed (Figure 5H), and
clusters C6-C7 with H3K27me3 in hESCs are unannotated pro-
moters enriched for DNA methylation, similar to promoter clus-
ters P16-P17 (Figure 5H, cluster C7). These ChIP-rich regions
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future study. Much like promoters, ChIP-rich regions show
little variation in DNA methylation across cell types (Fig-
ure S6C). Therefore, our analysis reveals that H3K4me1-pre-
dicted enhancer regions, which we previously showed to be
cell type specific (Heintzman et al., 2009), exhibit the most
dynamic DNA methylation changes.
Distinct Mechanisms of Epigenetic Repression
of Pluripotency Genes in Fibroblasts
The core pluripotent transcription factors OCT4, SOX2, and
NANOG are eachmarked in IMR90 cells by distinct combinations
of repressive modifications (DNA methylation, H3K9me3, and
H3K27me3). The OCT4 promoter is repressed through DNA
methylation, as previously demonstrated (Barrand and Collas,
2010; Ben-Shushan et al., 1993; Deb-Rinker et al., 2005). The
SOX2 promoter harbors both H3K27me3 and H3K9me3, and
NANOG shows an increase in promoter mCG and acquires
H3K27me3 (Figure 6A). To determine whether other genes are
regulated by these epigenetic modes of repression, we enumer-
ated nearly 1400 genes with >2-fold reduction in expression and
that acquired at least one repressive modification in IMR90 cells
relative to hESCs. From an unbiased hierarchical clustering
of these genes, we observe that only small groups of genes
follow the OCT4-, SOX2-, and NANOG-like patterns (Figure 6B).
Because of their limited expression, it is not surprising that few
genes are repressed in the same manner. However, these small,
uniquely marked sets of genes may provide insight to stem cell
biology or diseases such as cancer. For example, the NANOG-
like class contains KLF8, a known regulator of the reprogram-
ming factor KLF4. The OCT4-like class contains the cell cycle
regulator RAB25, which has a role in cell cycle regulation and
tumor invasion (Caswell et al., 2007). Because a common mech-
anism of epigenetic repression exists, these genes may also be
positively coregulated in a tissue-specific manner. This is most
evident with SOX2, a marker of neural stem cells. Many of the
SOX2-like class of genes have known roles in neurobiology,
such as CADPS, RIC3, ZIC5, and KIF1A.
Other combinations are more common. A large number of
DNA methylated promoters gain H3K27me3 (mC to mC/
H3K27me3), which may reflect a functional link between these
marks for a subset of genes. Previous studies have suggested
that H3K27me3-marked promoters are linked to DNA hyperme-
thylation in cancer cells (Ohm et al., 2007; Schlesinger et al.,
2007; Vire´ et al., 2006; Widschwendter et al., 2007). Here, we
note the reciprocal relationship also occurs. Not all statically
marked mC genes acquire H3K27me3, a smaller class gain
H3K9me3 (mC to mC/H3K9me3) (Figure 6B), suggesting dif-
ferent mechanisms. hESC bivalent promoters, which are
enriched for developmental regulators, are equally distributed
among three states in IMR90 cells: remaining H3K4/27me3 or
becoming H3K9/K27me3 or mC/H3K27me3 marked. GO anal-
ysis showed that the developmental regulators tend to be
marked by H3K9/27me3 in IMR90 cells (Figure 6C). Moreover,
genes dually marked for repression (mC/K27me3 and K27/
K9me3) constitute the majority of the 1400 genes examined.
Presumably, these added levels of epigenetic repression
decrease the likelihood of escaping gene repression and altering
cell fate. The multiple modes of repression suggest that severalmechanisms are in place to restrict dedifferentiation in lineage-
committed cells.
Repressive Chromatin Domains in Induced
Pluripotent Cells
iPSCs and hESCs are both pluripotent and share the ability to
self-renew. Furthermore, the global gene expression profiles
of IMR90-derived iPSCs are more similar to hESCs than the
original IMR90 cells (Yu et al., 2007). However, it remains to be
determined whether this is true of repressive chromatin
structure. By using iPSCs reprogrammed from IMR90 cells by
Yu et al., we askedwhether repressive domains are a key feature
of cell fate, and therefore are broad domains remodeled during
reprogramming, especially outside a few key gene promoter
regions. We observed that reprogramming results in a noticeably
reduced distribution of repressive domains (Figure S3), with
H3K9me3 reduced to 275 MB and H3K27me3 reduced to
195 MB, between the values observed in IMR90 cells (510 MB,
394 MB) and hESCs (148 MB, 119 MB). Despite the wider
coverage of H3K9me3 in IMR90 cells, there is more overlap
between iPSCs and hESCs (H3K9me3 = 105 MB, H3K27me3 =
102 MB) than between IMR90 cells and hESCs (H3K9me3 = 76
MB, H3K27me3 = 68 MB), indicating that reprogramming has
resulted in an epigenome that is more similar to the hESC epige-
nome (Figure 7A; Figure S3), consistent with previous observa-
tions (Maherali et al., 2007; Mikkelsen et al., 2008; Sridharan
et al., 2009).
On a global scale, the profiles of H3K9me3 and H3K27me3 in
iPSCs are similar to those in hESCs (Figure 7C). However,
regions of discordance exist, at times spanning genic regions
(Figure 7C). To dissect these differences, we defined three inter-
esting chromatin structures related to reprogramming. The first,
denoted iPS reprogrammed, are domains shared between
iPSCs and hESCs. The second, denoted iPS unchanged, are
marked in iPSCs and IMR90 cells, therefore not in a hESC-like
state. The third, denoted iPS unique, are domains not marked
in either hESCs or IMR90 cells. The iPS unchanged and iPS
unique groups have comparable genomic distributions, gener-
ally spanning intergenic regions of the genome, with only 12%
of H3K9me3 and 21% of H3K27me3 iPS domains intragenic
on average (Figure 7B). Thus, although there are subtle differ-
ences in repressive chromatin structure between iPSCs and
hESCs,most of these differences are confined to regions outside
of genes.
iPS-reprogrammed H3K27me3 domains cover nearly five
times as many gene promoters as the other groups (iPS
reprogrammed, 1736; iPSunchanged, 325; iPSunique, 362) (Fig-
ure 7D). This indicates that reprogramming has generally
reestablished the same H3K27me3 structure as hESCs at pro-
moters, and only a small fraction are incorrectly reprogrammed.
We do not observe the same phenomenon for H3K9me3, with
more genes in iPS unique (417) than iPS reprogrammed (201) or
iPS unchanged (173). These iPS/hESC differences in H3K9me3
structure at genepromoters is evident at several important epige-
netic and developmental genes. For example, the H3K9me3
demethylase JMJD1A is marked by H3K9me3 in both hESCs
and IMR90 cells but not iPSCs (Figure 7E). Also interesting, the
WNT receptor FZD10 retains the incorrect repressive mark:
H3K9/K27me3 in IMR90 cells, H3K27me3 in hESCs, yetCell Stem Cell 6, 479–491, May 7, 2010 ª2010 Elsevier Inc. 487
Figure 7. Comparison of Repressive Chro-
matin Structure in hESCs and iPSCs
(A) Overlap of repressive chromatin domains in
hESCs (blue), iPSCs (red), and IMR90 cells (yellow)
for H3K9me3 (left) and H3K27me3 (right). The total
coverage of these modifications is indicated
below. Regions related to reprogramming are
labeled: iPS reprogrammed regions, defined as
overlap of iPSCs and hESC but not IMR90 cells;
iPS unchanged regions, defined as overlap of
iPSCs and IMR90 cells but not hESCs; and iPS
unique regions.
(B) The average genic distribution of iPS
unchanged and iPS unique regions.
(C) Top: Difference in RPKM of iPS profiles com-
pared to hESC profiles for H3K9me3 (blue) and
H3K27me3 (yellow) throughout the length of chr20.
Bottom: Zoomed in views of genomic regions
having differences between iPSCs and hESCs.
(D) For the three types of iPS regions, the number
of gene promoters covered by H3K9me3 (top) or
H3K27me3 domains (bottom).
(E) Snapshots of repressive chromatin structure at
JMJD1A (left) and FZD10 (right) promoters, illus-
trating differences in iPSCs and hESCs.
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genes differentially expressed between several iPSC and hESC
lines (Chin et al., 2009). We tested whether H3K9me3 or
H3K27me3 was differentially enriched at these gene promoters
between IMR90-derived iPSCs and H1 hESCs. From the 3947
genes, 770 promoters are marked by H3K27me3 in iPSCs, of
which only 14.5% are not marked in hESCs (p = 1, Binomial,
expectation is 15.2%). In contrast, 160 promoters are marked
by H3K9me3 in iPSCs, 68% of which are not marked in hESC
(p = 0.0023, Binomial, expectation is 56.8%). Thus, it appears
that H3K9me3 contributes more than H3K27me3 to the differ-
ences in gene expression between iPSCs and hESCs. Perhaps488 Cell Stem Cell 6, 479–491, May 7, 2010 ª2010 Elsevier Inc.these observations indicate flexibility in
gene repression during reprogramming.
Our findings suggest that expanded
repressive domains are a key aspect of
differentiated cell fates, perhaps reducing
the plasticity seen in stem cells. Reprog-
ramming of somatic cells involves remod-
eling of these domains to reflect the hESC
epigenome. Therefore, it is likely that
partially reprogrammed iPSCs (piPSCs)
still harbor expanded chromatin domains
that prevent them from achieving pluripo-
tency. Our results call for future studies
of these chromatin marks in additional
hESCs, iPSCs, and piPSCs. Moreover,
expediting chromatin remodeling would
probably improve reprogramming effi-
ciency.
Conclusion
A fundamental question is how the iden-
tical genome sequence gives rise to adiversity of cell types with different gene expression profiles
and cellular functions. By comparing the epigenome of pluripo-
tent stem cells to that of a differentiated cell, we provide
evidence that lineage-committed cells are characterized by
significantly expanded repressive chromatin domains that selec-
tively affect genes involved in pluripotency and development,
suggesting that epigenetic mechanisms play a critical role in
cellular differentiation and maintenance of differentiated cellular
state. Recently, a similar conclusion was reached by examining
H3K9me2 in mouse ESCs and differentiated cells (Wen et al.,
2009). However, an independent analysis of the data via
a different block finding method has reached at a different
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H3K9me2 domain in mammalian cells (Filion and van Steensel,
2010; Wen et al., 2010). In the present work, the expansion of
H3K27me3 or H3K9me3-marked repressive domains was con-
firmed by several measures. First, the expansion of H3K27me3
was illustrated in independently derived data from multiple cell
types. Second, expanded H3K27me3 and H3K9me3 show
reduction in IMR90-derived iPSCs. Finally, we applied an inde-
pendent block-finding algorithm, TileHMM (Humburg et al.,
2008), used to reanalyze the Wen et al. H3K9me2 data (Filion
and van Steensel, 2010), and confirm the expansion of
H3K27me3 and H3K9me3 in IMR90-relative hESCs (Figure S3E).
Our result provides additional support to the general model
proposed by Wen et al. (2009).
Knockout studies of H3K9 methyltransferases and H3K27
methyltransferases lead to differentiation or developmental
defects (Dodge et al., 2004; Faust et al., 1998; O’Carroll et al.,
2001; Pasini et al., 2007; Peters et al., 2001; Tachibana et al.,
2002), suggesting that epigenetic mechanisms play a critical
role in cell fate determination. The expansion of H3K9me3 and
H3K27me3 domains in differentiated cells relative to hESCs
support this model. Reprogrammed cells reorganize their chro-
matin architecture to reflect the less repressive state of stem
cells. This suggests that inhibiting repressive chromatin struc-
ture would facilitate reprogramming either through inhibition of
HKMTs or overexpression of demethylases. Early evidence
supports this hypothesis (Shi et al., 2008a, 2008b; Wendt
et al., 2008). Collectively, this suggests that one aspect of epige-




ChIP was carried out as previously described with 500 mg chromatin and 5 mg
antibody (antibodies are listed in Supplemental Information) (Heintzman et al.,
2007; Kim et al., 2007). ChIP libraries for sequencing were prepared according
to Illumina protocols with minor modifications (see Supplemental Information)
(Illumina, San Diego, CA). Libraries were sequenced with the Illumina GAII
machine as per manufacturer’s protocols. After sequencing, cluster imaging,
base calling, andmapping were conducted with the Illumina pipeline (Illumina).
Cell Growth
IMR90 cells were grown as previously described (Kim et al., 2007). H1 embry-
onic stem cells were grown as previously described with Matrigel (BD Biosci-
ences) and mTeSR (Ludwig et al., 2006a, 2006b).
Data Normalization
For each chromatin mark and the input control, we divided the genome into
100 bp bins, counted the number of reads falling into each bin i, and computed
the number of reads per kilobase of bin per million reads sequenced (denoted
RPKMmark,i), with the exception of the input where RPKM is computed over the
five consecutive bins centered at i. Because input represents the entirety of the
genome and is not sequenced to saturation like ChIP data, a 500 bp bin is used
to reduce noise that occurs in a 100 bp window. Finally, normalized ChIP
enrichment is computed as DRPKM = RPKMmark,i – RPKMinput,i .
ChromaBlocks
To identify both peak-like and domain-like enrichment, a block is started for (1)
regions of 10 consecutive bins having average DRPKM R 1.5 with at least
5 bins above this threshold or (2) regions of 50 consecutive bins having
average DRPKM R 0.5 with at least 25 above this threshold. Once a block
is started, its boundaries are extended in both directions until reaching a regionof 50 bins having average DRPKM < 0.1 (Figure 1E). A full description is
provided in the Supplemental Experimental Procedures.
Quantifying DNA Methylation
For a given cytosine residue with CG context at position i in the genome, its
measure of mCG Mi is defined as the fraction of methylated cytosines called
out of all methylC-Seq reads spanning i. Given a region, we then use
%mCG as a measure of DNA methylation enrichment, defined as the sum of
the Mi for all CG dinucleotides in the region, divided by the total number of
CG dinucleotides in the region. The only exception is when calling promoters
enriched with DNA methylation for a given cell. Here, we use an absolute
measure of mCG with Mi = 1, and we define enriched promoters as those
with %mCGR 50% for a 1 kb window centered at the TSS.
Identifying Punctuated Chromatin Signatures
RefSeq promoters are clustered by chromatin signature via ChromaSig as
described (Hon et al., 2008) (motif width w = 4000 bp, wandering distance
d = 1000 bp, sanother = 2.5, and pa = 0.01). Putative enhancers in hESCs
and IMR90 cells were predicted on the basis of chromatin signatures
as described (Heintzman et al., 2007) and clustered by ChromaSig
(w = 4000 bp, d = 2000 bp, sanother = 2.5, and pa = 0.001). Regions of significant
ChIP enrichment of histone modifications were identified as described
(ChromaSig) (p value cutoff 1E-3), filtered to remove promoters, predicted
enhancers, gene 30 ends, and CTCF binding sites, and finally clustered by
ChromaSig (w = 4000 bp, d = 1000 bp, sanother = 2.5, and pa = 0.001). In all
instances, ChromaSig performed the clustering on all 11 chromatin modifica-
tion maps from both cell types simultaneously.
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SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
7 figures, and 12 tables and can be found with this article online at doi:
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